SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Care-plan review) — Clara Barton — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientClara Barton
Date of birth1821-12-25
IdentifiersMRN HR-NI024-SYN-TD; SSN (made up) 000-24-3357
Document date1874-06-16
AuthorEleanor Whitcombe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Five-month depression review in continuation treatment. [S]

History of Present Illness

Ms. Barton returns two months after her twelve-week review. The care manager's telephone PHQ-9 planned for about four weeks after that review was not completed: two calls in May went unanswered while she was at a week-long training course, and no further call was booked. She feels like herself again, with steady energy, and sleeps about seven hours. She has finished fifteen of sixteen CBT sessions and has joined the monthly peer support group. She works about 45 hours a week, walks most days, and sees friends weekly. She takes sertraline 100 mg every morning, has missed no doses, and has no side effects. She has had no suicidal thoughts. [S]

ElementDetail
Interval changeFeels like herself; steady energy
Missed contactTelephone PHQ-9 planned in May not completed
SleepAbout seven hours
PsychotherapyFifteen of sixteen CBT sessions; monthly peer support group
SafetyNo suicidal thoughts
PHQ-94

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy normal; weight back to her usual
GastrointestinalNegativeNo nausea or bleeding
PsychiatricNegativeMood good; no suicidal thoughts, elevated mood, or racing thoughts

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1874-01-20 to 1874-03-03completedS
Sertraline 100 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1874-03-03activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1874-06-16Body height152cmS
1874-06-16Body weight51.6kgS
1874-06-16Body mass index (BMI) [Ratio]22.3kg/m2S
1874-06-16Systolic blood pressure120mm[Hg]S
1874-06-16Diastolic blood pressure74mm[Hg]S
1874-06-16Heart rate70/minS
1874-06-16Respiratory rate14/minS
1874-06-16Body temperature36.7CelS
1874-06-16Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1874-06-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S

Physical Exam

Vital signs recorded on 1874-06-16; see the Vital Signs section. [S]

SystemFinding
GeneralWell, brisk, and cheerful
Mental statusAlert; mood "like myself"; affect full and reactive; thought process linear; no suicidal ideation; insight and judgment good

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostrationactiveconfirmed F33.1S — Synthetic modern diagnosis. Her periods of depression and nervous prostration are documented in her own words (D); calling them major depression is a retrospective interpretation (R), and no diagnosis was made in her lifetime.
Occupational burnout after eighteen months leading field medical relief in a war zoneactiveconfirmed Z73.0S — Synthetic contributing factor echoing her documented exhaustion after wartime relief work; burnout is an occupational phenomenon, not a mental disorder.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPHQ-9Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today4: remission
SurveyMonthly PHQ-9 between the twelve-week review and todayAt least monthly during acute treatmentDeferredNot done, a deviation from the protocol: the care-manager telephone PHQ-9 planned for about four weeks after the twelve-week review was not completed after two unanswered calls, leaving nine weeks unmeasured. No harm resulted judging by today's review: she reached remission and had no suicidal thoughts. Corrective action: the registry now books a callback within a week after any unanswered call and alerts Dr. Whitcombe if a scheduled score is missing
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visit during active treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Protective factors stronger than at intake. Safety plan reviewed
Medication safetyAdherence and adverse-effect reviewEvery visit during active treatmentCompleted todayNo missed doses; no side effects
Self-managementPsychotherapy, sleep, work hours, and social contactEvery visit during active treatmentCompleted todayFifteen of sixteen CBT sessions; sleep about seven hours; 45-hour week; monthly peer support group
LaboratoryLithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)Only on those drugsNot indicatedTreated with an SSRI only

Goal progress:

Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: PHQ-9 in two to three months; preventive visit in October. Next scheduled visit 1874-10-13: periodic adult preventive visit. [S]